Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 130 M145 M165 M176 M115 M124 M 580 M Research & development —————— — Operating income 132 M110 M103 M135 M138 M151 M 527 M Non-Operating Income, Total ———-14 M—— — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses ———-14 M—— — Unusual income/expense —————— — Pretax income 45 M24 M12 M34 M64 M78 M 188 M Equity in earnings 21 M8 M18 M15 M21 M24 M 78 M Taxes 24 M22 M13 M-3 M20 M24 M 54 M Non-controlling/minority interest 9 M-2 M-11 M-3 M00 -14 M After tax other income/expense 1 M6 M7 M-14 M-2 M-4 M -13 M Net income before discontinued operations 12 M4 M10 M40 M44 M54 M 148 M Discontinued operations —————— — Net income 12 M4 M10 M40 M44 M54 M 148 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 12 M4 M10 M40 M44 M54 M 148 M Basic earnings per share (Basic EPS) 0.050.020.040.160.180.22 0.6 Diluted earnings per share (Diluted EPS) 0.050.020.040.160.180.22 0.6 Average basic shares outstanding 243 M243 M243 M243 M244 M244 M — Diluted shares outstanding 243 M243 M243 M244 M244 M245 M — EBITDA 243 M113 M217 M255 M223 M227 M 922 M EBIT 111 M102 M85 M-238 M117 M127 M 91 M Cost of revenue 3.06 B3.12 B3.19 B3.51 B2.91 B3.13 B 12.74 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 132 M131 M132 M493 M106 M100 M 831 M